Clinical Trial Update: Dexamethasone Prior to Re-treatment With Enzalutamide in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Previously Treated With Enzalutamide and Docetaxel [NA]

View source ↗

Summary

This terminated trial evaluated dexamethasone prior to enzalutamide re-treatment in metastatic castration-resistant prostate cancer patients previously treated …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• Decadron (Dexamethasone)
• XTANDRA (enzalutamide)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Hormone-Resistant Prostate Cancer, Metastatic Prostate Carcinoma | NA | Status: TERMINATED | Results posted: 2018-07-12